Anxiety and depression in COPD patients: The roles of gender and disease severity

Respiratory Medicine
Fabiano Di MarcoStefano Centanni

Abstract

The aim of our study was to assess the prevalence of anxiety and depression in the whole chronic obstructive pulmonary disease (COPD) population and in subgroups according to sex and severity classification. A secondary objective was to evaluate the possible differences between patients with and without a significant high level of anxiety, depression, or both, and finally to find out a correlation between psychological aspects, symptoms, functional parameters, and quality of life (QoL). Two hundred and two COPD patients were enrolled. Their levels of anxiety, depression, dyspnea, and QoL were assessed using specific questionnaires. One hundred and fourteen sex- and age-matched healthy subjects were used as the control population. The prevalences of anxiety and depression were high (28.2% and 18.8%) in COPD even when it was of mild degree, compared to the control group, in which the prevalence of anxiety and depression were 6.1% and 3.5%, respectively. Female patients had higher levels of anxiety and depression and worse symptom-related QoL. Female patients reported a higher level of dyspnea than males for the same level of ventilatory impairment. Dyspnea was more strongly correlated with depression in women than in men. Anxiety...Continue Reading

References

Mar 1, 1990·Journal of Behavior Therapy and Experimental Psychiatry·G BertolottiE Sanavio
Sep 1, 1989·Stroke; a Journal of Cerebral Circulation·B Agrell, O Dehlin
Oct 1, 1970·Journal of Educational Psychology·E Gaudry, C D Spielberger
Mar 1, 1982·Archives of Internal Medicine·A J McSweenyR M Timms
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·B R Celli
Nov 1, 1996·The European Respiratory Journal·C M BosleyG M Cochrane
Aug 24, 2000·Respiratory Medicine·S CentanniA Piazzini
May 29, 2001·International Journal of Geriatric Psychiatry·A M YohannesR C Baldwin
Feb 21, 2002·The European Respiratory Journal·H C F McCathieR L Tate
Jan 1, 1965·Archives of General Psychiatry·W W ZUNG
Oct 1, 2003·The European Respiratory Journal·R Antonelli-IncalziUNKNOWN SaRA Investigators
Jul 16, 2005·International Journal of Geriatric Psychiatry·Kari KvaalKnut Engedal
Aug 2, 2005·The European Respiratory Journal·E J WagenaC P van Schayck

❮ Previous
Next ❯

Citations

Apr 22, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Brian Mieczkowski, Michael E Ezzie
May 31, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Amy BlakemorePeter A Coventry
Feb 1, 2013·Pulmonary Medicine·Pierachille SantusAntonio Spanevello
Mar 8, 2011·Journal of Women's Health·Shiva D RahmanianMary Ellen Wewers
Dec 6, 2012·Journal of Women's Health·Carlos H MartinezMeiLan K Han
Aug 12, 2008·Journal of General Internal Medicine·Rebecca E SchanePrescott G Woodruff
Mar 8, 2007·Respiratory Research·Juan P de TorresBartolome R Celli
Apr 14, 2007·American Journal of Respiratory and Critical Care Medicine·Fernando J MartinezUNKNOWN National Emphysema Treatment Trial Research Group
Aug 4, 2007·American Journal of Respiratory and Critical Care Medicine·Meilan K HanFernando J Martinez
Jan 6, 2009·BMC Pulmonary Medicine·Pilar Carrasco-GarridoRodrigo Jimenez-Garcia
Mar 11, 2010·Respiratory Research·Nicholas D GiardinoUNKNOWN NETT Research Group
Nov 3, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Cindy J WongDonna Rennie
Oct 26, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Renee D GoodwinDavid A Fedoronko
Jun 2, 2012·World Journal of Gastroenterology : WJG·Xiao-Jing LiLan Zhang
May 28, 2009·Current Psychiatry Reports·Abhishek Jain, Sermsak Lolak
Jul 31, 2008·Der Nervenarzt·S HaackM Jäger
Aug 13, 2013·Multidisciplinary Respiratory Medicine·Athanasios TselebisNikolaos Tzanakis
Oct 24, 2012·Tobacco Induced Diseases·Britt-Marie EklundInger Lindberg
Jul 4, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Adrian LoerbroksTai Hing Lam
Jun 27, 2007·Journal of Palliative Medicine·Graeme M RockerPaul Hernandez
Aug 26, 2006·American Journal of Respiratory and Critical Care Medicine·David M Mannino
Jun 14, 2012·Postgraduate Medicine·Christine Garvey
Nov 21, 2007·COPD·Adam L FriedlanderRussell P Bowler
Mar 17, 2007·COPD·Venkata Rebbapragada, Nicola A Hanania
May 21, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Shambhu AryalDavid M Mannino
Apr 27, 2010·Chest·Roshan Brito-MutunayagamUNKNOWN North West Adelaide Cohort Health Study Team
Oct 6, 2009·Chest·Cornelia SchneiderChristoph R Meier
Jan 21, 2016·Multidisciplinary Respiratory Medicine·Christian ZilzStephan Budweiser
Sep 28, 2010·Revista española de geriatría y gerontología·María Magdalena Medinas AmorósFeliu Renom Sotorra
Mar 5, 2016·Lung·Carlos Martinez RiveraMarc Miravitlles
Dec 14, 2010·Archivos de bronconeumología·Juan Pablo de Torres Tajes, Ciro Casanova Macario
Jul 9, 2010·Revue des maladies respiratoires·C RaherisonA Prudhomme

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.